Dr. Stephen S. Lane.
​
FORT WORTH, Texas—Alcon has appointed Stephen (Steve) S. Lane, MD as chief medical officer (CMO) and global head franchise clinical strategy. He will join the company on June 1.

In his new role, Dr. Lane will lead the integration of scientific, clinical and commercial priorities across Alcon’s surgical and vision care franchises, with a focus on the needs of patients and eyecare practitioners. Dr. Lane will also support the generation of surgical and vision care clinical evidence and represent Alcon to academic, scientific, and industry communities, and government agencies.

“All of us at Alcon are pleased to welcome Steve to the team,” said Franck Leveiller, senior vice president, global head R&D, Alcon. “His extensive experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory environment complements Alcon’s medical device innovation and commercial execution strategy. Dr. Lane’s knowledge will be invaluable as we continue to develop products that protect and preserve sight, and help eyecare practitioners deliver the best visual outcomes for their patients.”

For the past 32 years, Dr. Lane has been a world-renowned ophthalmologist specializing in cataract surgery, cornea/external diseases, anterior segment surgery, LASIK, and refractive surgery. He is a founding partner of Associated Eye Care, past president of the American Society of Cataract Surgeons (ASCRS), serves on the editorial boards for several ophthalmic journals, is a distinguished lecturer, and has published numerous academic articles and book chapters. In addition, Steve is an adjunct professor of ophthalmology at the University of Minnesota, co-chair of the ASCRS Foundation, and a visiting faculty member of ORBIS International, an Alcon partner.

Throughout his career, Dr. Lane has been honored with numerous awards, including The American Academy of Ophthalmology Honor Award, Senior Achievement Award and Secretariat Award. He has been named a Top Doctor, including recognition in the top 1 percent of ophthalmologists, by U.S. News, and one of the “34 Best Ophthalmologists in America” by Becker’s ASC Review.